3406 related articles for article (PubMed ID: 6176752)
21. A plasma membrane antigen highly associated with oat-cell carcinoma of the lung and undetectable in normal adult tissue.
Bell CE; Seetharam S
Int J Cancer; 1976 Nov; 18(5):605-11. PubMed ID: 62723
[TBL] [Abstract][Full Text] [Related]
22. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
[TBL] [Abstract][Full Text] [Related]
23. T/Tn pancarcinoma autoantigens: fundamental, diagnostic, and prognostic aspects.
Springer GF; Desai PR; Ghazizadeh M; Tegtmeyer H
Cancer Detect Prev; 1995; 19(2):173-82. PubMed ID: 7750105
[TBL] [Abstract][Full Text] [Related]
24. Analysis of soluble melanoma cell membrane antigens in metastatic cells of various organs and further studies of antigens present in primary melanoma.
Hollinshead AC
Cancer; 1975 Oct; 36(4):1282-8. PubMed ID: 51680
[TBL] [Abstract][Full Text] [Related]
25. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
26. Immunologic status in lung cancer.
Brugarolas A; Takita H
Chest; 1973 Oct; 64(4):427-30. PubMed ID: 4355273
[No Abstract] [Full Text] [Related]
27. Differentiation-related expression of the Thomsen-Friedenreich glycotope in developing human lung and in lung carcinoma: lack of association with malignancy.
Toma V; Sata T; Vogt P; Komminoth P; Heitz PU; Roth J
Cancer; 1999 May; 85(10):2151-9. PubMed ID: 10326693
[TBL] [Abstract][Full Text] [Related]
28. Phytohemagglutinin skin tests in cancer patients.
Zuckerman KS; LoBuglio AF
Cancer; 1977 Jun; 39(6):2355-61. PubMed ID: 266970
[TBL] [Abstract][Full Text] [Related]
29. Histocompatibility antigens and solid malignant neoplasms.
Tarpley JL; Chretien PB; Rogentine GN; Twomey PL; Dellon AL
Arch Surg; 1975 Mar; 110(3):269-71. PubMed ID: 163628
[TBL] [Abstract][Full Text] [Related]
30. Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.
Freedman RS; Bowen JM; Atkinson EN; Scott W; Wagner S
Cancer Immunol Immunother; 1984; 17(2):142-6. PubMed ID: 6088033
[TBL] [Abstract][Full Text] [Related]
31. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
García MS; Barañao RI; Fernández O; Rumi LS
Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
[TBL] [Abstract][Full Text] [Related]
32. Delayed hypersensitivity skin reactions to antigens on human tumors.
Herberman RB
Cancer; 1974 Oct; 34(4 Suppl):suppl:1469-73. PubMed ID: 4609389
[No Abstract] [Full Text] [Related]
33. Oncofetal antigen-I: distribution in human tumors.
Rees WV; Irie RF; Morton DL
J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
[TBL] [Abstract][Full Text] [Related]
34. Survey of human polyomavirus (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma.
Hogan TF; Padgett BL; Walker DL; Borden EC; Frias Z
Prog Clin Biol Res; 1983; 105():311-24. PubMed ID: 6304768
[TBL] [Abstract][Full Text] [Related]
35. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
36. Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells.
Weese JL; Herberman RB; Hollinshead AC; Cannon GB; Keels M; Kibrite A; Morales A; Char DH; Oldham RK
J Natl Cancer Inst; 1978 Feb; 60(2):255-63. PubMed ID: 74413
[No Abstract] [Full Text] [Related]
37. BCM-IMx behaviour in patients with lung diseases.
Allende MT; Hernández J; Fernández Fernández M; Fernández Llana B; Suarez B; Ruibal A
Bull Cancer; 1991; 78(9):843-5. PubMed ID: 1661198
[No Abstract] [Full Text] [Related]
38. Monoclonal antibodies specific for two different histological types of human lung carcinoma.
Saji S; Zylstra S; Schepart BS; Ghosh SK; Jou YH; Takita H; Bankert RB
Hybridoma; 1984; 3(2):119-29. PubMed ID: 6090307
[TBL] [Abstract][Full Text] [Related]
39. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
Burdick JF; Wells SA; Herberman RB
Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
[TBL] [Abstract][Full Text] [Related]
40. Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization.
Disis ML; Schiffman K; Gooley TA; McNeel DG; Rinn K; Knutson KL
Clin Cancer Res; 2000 Apr; 6(4):1347-50. PubMed ID: 10778962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
